Macrophages in Tumor Microenvironments and the Progression of Tumors
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, TAMs induce immunosuppression via release of IL-10 and TGF-β, both of which inhibit the development of cytotoxic T cells and NK cells, and may fuel the appearance of more M2-like TAMs at the tumor site (8, 67, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cancer, tumor-associated macrophages (TAMs) have been known to either promote or hinder neoplasia (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
In the citing paper
“In contrast, M2 macrophages (CD163) play an anti-inflammatory and pro-tumor role”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
In the citing paper
“TAMs often exhibit an “M2-like” phenotype [324].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 2×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“, tumor necrosis factor-α (TNF-α)) [6] (Figure 1).”
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“Finally, M2c macrophages are induced by IL-10, transforming growth factor-β (TGF-β), or glucocorticoids (GCs) [7] (Figure 1).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 7×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
Background
Research works printed but not linked: 12
- 2008, Journal of Immunology, 15, 3733
- 2002, American Journal of Pathology, 161, 947, 10.1016/s0002-9440(10)64255-1 · DOI · Paper page
- 2005, Oncology Reports, 14, 425
- 1996, Journal of Immunology, 156, 73
- 1997, Journal of Immunology, 159, 770
- 1995, Journal of Immunology, 154, 1280
- 2000, Cancer Research, 60, 2632
- 1999, International Journal of Cancer, 84, 539
- 1984, Annual Review of Immunology, 2, 283, 10.1146/annurev.iy.02.040184.001435 · doi:10.1146/annurev.iy.02.040184.001435 · Paper page
- 2003, Cancer Research, 63, 8360
- 1995, Cancer Research, 55, 1499
- 2003, Cancer Research, 63, 7853
Cited by
Items 601–700 of 1,000
Kabasawa, T., Ohe, R., Aung, N. Y., Urano, Y., Kitaoka, T., Tamazawa, N., Utsunomiya, A., & Yamakawa, M. (2021) · Scientific Reports · doi:10.1038/s41598-020-80694-3 · Cited by 16
Li, Z., Zhang, L., Liu, F., Li, P., He, J., Kirkwood, C. L., Sohn, J., Chan, J. M., Magner, W. J., & Kirkwood, K. L. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105401 · Cited by 15
Wei, Z., Yang, M., Feng, M., Wu, Z., Rosin‐Arbesfeld, R., Dong, J., & Zhu, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.713331 · Cited by 16
“In most cases, TAMs are thought to be M2 and related to poor prognosis (Hao et al., 2012); however, the scenario is more complex in colon cancer.”
Spinelli, F. M., Rosales, P., Pluda, S., Vitale, D. L., Icardi, A., Guarise, C., Reszegi, A., Kovalszky, I., García, M. G., Sevic, I., et al. (2022) · IUBMB Life · doi:10.1002/iub.2604 · Cited by 15
Zheng, X., Chen, J., Nan, T., Li, Z., Lan, J., Jin, X., Cai, Y., Liu, H., & Chen, W. (2022) · Bioengineered · doi:10.1080/21655979.2022.2075300 · Cited by 15
“M2 macrophages play important roles in tumorpromoting functions, including tumor metastasis, angiogenesis, growth, immunosuppression, and therapeutic resistance [4,5].”
BackgroundVasaturo, A., Verdoes, M., de Vries, I. J. M., Torensma, R., & Figdor, C. G. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.11.007 · Cited by 17
Phenotypic characterization of macrophages in the BMB sample of human acute leukemia
Jian-xin, S., Wen, Y., Li, R.-W., Dong, T., Tang, Y., Zhang, J., & Sa, Y.-L. (2020) · Annals of Hematology · doi:10.1007/s00277-020-03912-y · Cited by 15
Savaş, E. M., Oğuz, S. H., Samadi, A., Işıkhan, S. Y., Ünlütürk, U., Lay, İ., & Gürlek, A. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0074 · Cited by 15
Kulshrestha, R., Dhanda, H., Pandey, A., Singh, A. K., & Kumar, R. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1776117 · Cited by 15
Dual Functionalized Lactococcus lactis Shows Tumor Antigen Targeting and Cytokine Binding in Vitro
Zahirović, A., Plavec, T. V., & Berlec, A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.822823 · Cited by 14
“, primarily monocytes and macrophages) also drive inflammation in the CRC microenvironment (Hao et al., 2012).”
BackgroundYang, X., Wu, M., Yan, X., Zhang, C., Luo, Y., & Yu, J. (2023) · Molecules · doi:10.3390/molecules28093682 · Cited by 14
“On the other hand, M2 macrophages are primarily involved in angiogenesis, tissue remodeling, wound healing, anti-inflammatory activity, and T cell immune function regulation by secreting various cytokines and chemokines, including IL-10, Arg1, Fizz1, Ym1, CD206, and low levels of IL-12 [6,7].”
BackgroundAhmadpour, S., Habibi, M., Ghazi, F. S., Molazadeh, M., Pashaie, M. R., & Mohammadpour, Y. (2024) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2024.100823 · Cited by 16
Matias, B. F., Oliveira, T. M. D., Rodrigues, C. M., Abdalla, D. R., Montes, L. N., Murta, E. F. C., & Michelin, M. A. (2013) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s12268 · Cited by 16
Chong, Z. X., Ho, W. Y., Yeap, S.-K., Wang, M., Chien, Y., Verusingam, N. D., & Ong, H. K. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000535 · Cited by 18
“75 In lung cancer, a similar phenomenon was observed in which M1-like macrophages were found to have anti-tumoural properties while M2-like macrophages were said to have pro-tumoural properties.”
InfluentialTumor microenvironment of adult T-cell leukemia/lymphoma
Takeuchi, M., Miyoshi, H., & Ohshima, K. (2021) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.21007 · Cited by 16
Roy, A. M., & George, S. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.47 · Cited by 14
Preclinical studies of 5-fluoro-2′-deoxycytidine and tetrahydrouridine in pediatric brain tumors
Morfouace, M., Nimmervoll, B. V., Boulos, N., Patel, Y. T., Shelat, A. A., Freeman, B. B., Robinson, G. W., Wright, K. D., Gajjar, A. J., Stewart, C. F., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1965-0 · Cited by 14
“The lack of in vivo efficacy may be explained by chemoresistance that could be due to tumor cell-intrinsic changes [36], extrinsic factors such as cytokines and growth factors [37] emphasizing the importance of the tumor microenvironment, especially the presence of tumorassociated macrophages that could play a critica…”
BackgroundKirita, K., Ishii, G., Matsuwaki, R., Matsumura, Y., Umemura, S., Matsumoto, S., Yoh, K., Niho, S., Goto, K., Ohmatsu, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083537 · Cited by 14
“CD204(+) macrophages reportedly exhibit a tumor-promoting function in several tumors by secreting matrix metalloproteinase (MMP)-1, MMP-3, MMP-7, MMP-9, MMP-12, vascular endothelial growth factor (VEGF), and transforming growth factor (TGF)-b [26,27].”
BackgroundKakhi, Z., Frisch, B., Bourel‐Bonnet, L., Hemmerlé, J., Pons, F., & Heurtault, B. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.11.027 · Cited by 15
Big Data Offers Novel Insights for Oncolytic Virus Immunotherapy
Swift, S. L., & Stojdl, D. F. (2016) · Viruses · doi:10.3390/v8020045 · Cited by 14
“M1/M2 Macrophages: Typically, M1 macrophages are considered pro-inflammatory and immunostimulatory (and therefore potentially beneficial during OVIT), while M2 macrophages are considered anti-inflammatory and immunosuppressive [51].”
BackgroundEffect of Th1/Th2 cytokine administration on proinflammatory SKOV-3 cell activation
Mielczarek‐Palacz, A., Sikora, J., Kondera‐Anasz, Z., Mickiewicz, P., & Mickiewicz, A. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.53143 · Cited by 14
“Different cytokines, including proinflammatory factors, such as IL-1b and IL-6 or IL-12, were demonstrated in normal ovarian tissue and were more pronounced in tumor cells, especially in ovarian cancer cells [16].”
BackgroundThe duality of macrophage function in chronic lymphocytic leukaemia
Chen, Y.-C. E., Mapp, S., Blumenthal, A., Burgess, M. L., Mazzieri, R., Mattarollo, S. R., Mollee, P. N., Gill, D. S., & Saunders, N. A. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.03.006 · Cited by 16
“ADCC/ADP tumour cell killing via activation of phosphatases such as Ship1/2, which catalyse the conversion of PIP3 to PIP2 thus blocking FcγR-dependent activation [88, 89] (Figure 3).”
BackgroundKonkol, Y. M., Vuorikoski, H., Streng, T., Tuomela, J. M., & Bernoulli, J. (2019) · Translational Andrology and Urology · doi:10.21037/tau.2019.02.03 · Cited by 14
Insights on TAM Formation from a Boolean Model of Macrophage Polarization Based on In Vitro Studies
Marku, M., Raynal, F., Verstraete, N., Domagała, M., Madrid-Mencía, M., Poupot, M., Fournié, J.-J., Ysebaert, L., & Pancaldi, V. (2020) · Cancers · doi:10.3390/cancers12123664 · Cited by 16
“In the context of Chronic Lymphocytic Leukaemia (CLL) it has been proposed that Nurse-like cells (NLC), which are specific form of TAMs identified in this malignancy, are polarized in response to CSF-1 and HMGB1 proteins released by CLL cancer cells.”
BackgroundInfluentialAchita, A. B. P. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000318 · Cited by 17
“The M2c phenotype is induced by IL-10, TGF-β, and glucocorticoid (GC) hormones, and has a role in tissue healing and remodeling [20].”
BackgroundMacrophages and Tissue Homeostasis: From Physiological Functions to Disease Onset
Li, Y., Chen, H., & Zhou, S. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl42706 · Cited by 14
Bao, W., Qu, X., Wang, Y., Huang, D., Zhang, H., Dong, M., Sun, H., Yang, Z., & Li, X. (2026) · MedComm · doi:10.1002/mco2.70599 · Cited by 15
Rasmussen, M., Fredsøe, J., Salachan, P. V., Blanke, M. P. L., Larsen, S. H., Ulhøi, B. P., Jensen, J. B., Borre, M., & Sørensen, K. D. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00540-x · Cited by 13
“Thus, increased levels of M2 polarized macrophages likely re fl ects an immunosuppressive environment in subtype S3 33 , while change in the speci fi c T-cell subsets require additional investigation.”
Jin, S., Liu, W., He, X., Zhang, Y., Chen, W., Wu, Y., & Liu, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112365 · Cited by 13
Colaço, M., Cruz, M. T., de Almeida, L. P., & Borges, O. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101308 · Cited by 14
“They also upregulate enzymes like indoleamine 2,3-dioxygenase (IDO) and inducible nitric oxide synthase (iNOS) [114].”
BackgroundWada, S., Matsushita, Y., Tazawa, H., Aoi, W., Naito, Y., Higashi, A., Ohshima, H., & Yoshikawa, T. (2015) · Free Radical Research · doi:10.3109/10715762.2014.997230 · Cited by 13
Jarboe, T., Tuli, N. Y., Chakraborty, S., Maniyar, R. R., DeSouza, N., Li, X.-M., Moscatello, A. L., Geliebter, J., & Tiwari, R. K. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-83282-7_1 · Cited by 13
Yeh, K.-Y., Wu, T.-H., & Wu, T.-L. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.001 · Cited by 15
Mulens‐Arias, V., Nicolás‐Boluda, A., Silva, A., & Gazeau, F. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800079 · Cited by 13
MACROPHAGE FUNCTIONAL DISORDERS IN RHEUMATOID ARTHRITIS AND ATHEROSCLEROSIS
Герасимова, Е. В., & Попкова, Т. В. (2018) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2018-486-493 · Cited by 14
Morishita, A., Gerber, A., Ch, G., Zelonina, T., Chada, K. K., & D'Armiento, J. M. (2018) · PubMed · Cited by 13
Zhang, J., Tian, W., Wang, F., Liu, J., Huang, J., Duangmano, S., Liu, H., Liu, M., Zhang, Z., & Jiang, X. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2230018 · Cited by 13
Self-citationAntimetastatic effect of glycoprotein isolated from rice bran on colon 26-M3.1 cell line
Park, H., Yoon, T. J., Lee, W., Kim, Y., & Choi, H. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.03.014 · Cited by 13
Shekarriz, R., Janbabaei, G., & Kenari, S. A. (2018) · PubMed Central · doi:10.22034/apjcp.2018.19.1.27 · Cited by 13
“Macrophages have important biological functions namely an important role in neovascularization process, tumor growth and metastasis (Hao et al., 2012).”
BackgroundBadiuk, S. R., Thiessen, J. D., Vareki, S. M., Foster, P. J., Chen, J. Z., & Wong, E. (2022) · Physics and Imaging in Radiation Oncology · doi:10.1016/j.phro.2022.02.016 · Cited by 17
“M2 macrophage polarization changes antigen presentation, receptor expression, and cytokine production, aligning with immunoinhibitory, pro-tumor, and angiogenic effects when the tumor establishes itself [57].”
BackgroundInhibition of renalase drives tumour rejection by promoting T cell activation
Guo, X., Jessel, S., Qu, R., Kluger, Y., Tian-min, C., Hollander, L. L., Safirstein, R. L., Nelson, B., Cha, C. H., Bosenberg, M., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.01.002 · Cited by 12
Yao, Z., Zhang, H., Zhang, X., Zhang, Z., Jie, J., Xie, K., Li, F., & Tan, W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.923768 · Cited by 12
“Macrophages, including M1 and M2 macrophages, are mainly involved in innate immunity and help initiate adaptive immunity (Hao et al., 2012).”
BackgroundSelf-citationTomonobu, N., Kinoshita, R., Wake, H., Inoue, Y., Ruma, I. M. W., Suzawa, K., Gohara, Y., Komalasari, N. L. G. Y., Jiang, F., Murata, H., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810300 · Cited by 12
“In the cancer milieu, macrophages, especially M2-type macrophages, play a crucial role in fostering cancer cells toward their aggressive metastatic forms [40].”
BackgroundKanwore, K., Kanwore, K., Guo, X., Xia, Y., Zhou, H., Zhang, L., Adzika, G. K., Joseph, A.-A., Ayanlaja, A. A., Mu, P., et al. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00300-7 · Cited by 12
“Conversely, in the tumor microenvironment, these mechanisms enhance the proliferative cells’ survival and adaptation to the immune response, enabling them to evade immunosurveillance and ultimately scaffolding cancer progression [33, 34].”
BackgroundRole of the ubiquitin–proteasome system on macrophages in the tumor microenvironment
Xiao, Y., Liu, R., Li, N., Li, Y., & Huang, X. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31180 · Cited by 12
Gao, H., Chen, Z., Yao, Y., He, Y., & Hu, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1453090 · Cited by 13
Liao, L.-C., Hu, B., & Zhang, S. (2019) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000090 · Cited by 12
Sørensen, M. D., Nielsen, O., Reifenberger, G., & Kristensen, B. W. (2020) · Brain Pathology · doi:10.1111/bpa.12921 · Cited by 12
“In contrast to IBA-1, genes related to both M1-and M2 polarization, for example, CD204 were significantly lower in IDH-mutant astrocytic gliomas (69–73), suggesting innate immune activation is suppressed in tumors carrying an IDH mutation.”
Sánchez-Reyes, K., Pedraza‐Brindis, E. J., Hernández‐Flores, G., Bravo‐Cuéllar, A., López-López, B. A., Rosas‐González, V. C., & Ortiz‐Lazareno, P. C. (2019) · Innate Immunity · doi:10.1177/1753425919848841 · Cited by 13
“In response to the activation of these factors a secretion high of pro-inflammatory cytokines such as IL-1, TNF-a, IL-12, IL- 6, IL-23, as well as Reactive Oxygen Species (ROS), and nitrogen intermediates are induced, which can induce death in cancer cells.(7,13) In contrast, alternatively activated macrophages (M2 ma…”
BackgroundInfluentialCandela, M. E., Addison, M., Aird, R., Man, T.-Y., Cartwright, J. A., Ashmore-Harris, C., Kilpatrick, A. M., Starkey Lewis, P. J., Drape, A., Barnett, M., et al. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00393-3 · Cited by 11
“AAMs, are knownto secreteanti-in fl ammatory cytokinessuch as IL-10 and TGF-β 50 .”
Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancer
Kang, B.-H., Jang, B., & Kim, I. A. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06818-7 · Cited by 11
“M2 macrophages secrete anti-inflammatory cytokines to induce immune tolerance, which have been studied as a prognostic biomarker [38, 39].”
BackgroundAngiogenesis unveiled: Insights into its role and mechanisms in cartilage injury
Wang, C., Gong, S., Liu, H., Cui, L., Ye, Y., Liu, D., Liu, T., Xie, S., & Li, S. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112537 · Cited by 11
“Macrophages exhibit functional plasticity, with M 1 macrophages generally promoting inflammation, whereas M 2 macrophages are associated with tissue repair and angiogenesis (Hao et al., 2012).”
BackgroundNguyen, D. K., Kang, M., Oh, S., Park, H.-J., Kim, S. H., Yu, J. H., Lee, Y., Lee, H. S., Yang, J. W., Seo, Y., et al. (2024) · Animal Cells and Systems · doi:10.1080/19768354.2024.2442401 · Cited by 11
Zurochka, A. V., Александрович, З. В., Dobrynina, M. A., & Гриценко, В. А. (2021) · Medical Immunology (Russia) · doi:10.15789/1563-0625-ipo-2216 · Cited by 13
Anand, S., Heusinkveld, L. E., Cheng, C., Lefatshe, L., Silva, P. D., Hasan, T. G., & Maytin, E. V. (2022) · Photochemistry and Photobiology · doi:10.1111/php.13706 · Cited by 11
“IL-1, IL-6, IL-12 and TNFa, which promote tumor eradication (2,64,68,69).”
BackgroundALDOC regulated the biological function and immune infiltration of gastric cancer cells
Chen, L., Zeng, Y., Ren, B., Wang, X., Zhao, F., Du, J., Zhang, R., & Deng, J. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106407 · Cited by 14
Yokota, S., Kaji, K., Yonezawa, T., Momoi, Y., & Maeda, S. (2023) · The Veterinary Journal · doi:10.1016/j.tvjl.2023.105992 · Cited by 11
Weiss, A., D’Amata, C., Pearson, B. J., & Hayes, M. N. (2024) · eLife · doi:10.7554/elife.93077 · Cited by 11
“…and surrounding p53EPS tumors, we co-injected our oncogene combination into tp53 -/- embryos carrying a Tg( tnfa :EGFP) transgenic marker of activated and pro-inflammatory phagocytes ( Hao et al., 2012 ; Nguyen-Chi et al., 2015 ), and observed enrichment of tnfa :EGFP single-positive cells in her4.”
GDF-15 upregulates the SLC7A11/GPX4 signaling axis and promotes mitoxantrone resistance in AML cells
Lu, Q., & Liao, Y. (2025) · European journal of medical research · doi:10.1186/s40001-025-02787-x · Cited by 11
Noncanonical roles of the immune system in eliciting oncogene addiction
Casey, S. C., Bellovin, D. I., & Felsher, D. W. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.02.003 · Cited by 11
“Suppressive lymphocytes [81] and macrophages [82] can lead to a dampening of the antitumor response and consequently, disease progression.”
BackgroundSu, P., Peng, Z., Xu, B., Yang, B., & Jin, F. (2021) · PeerJ · doi:10.7717/peerj.12383 · Cited by 11
Bőgel, G., Murányi, J., Szokol, B., Kukor, Z., Móra, I., Kardon, T., Őrfi, L., & Hrabák, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08670 · Cited by 11
“At the same time, arginase 1, another enzyme using L-arginine substrate is a marker of alternative (M2) activation of macrophages, at least in rodents, and IL-10 or TGF-β are cytokines produced by M2 polarized cells [Hao et al., 2012].”
BackgroundXu, J.-L., Che, Y.-H., Liu, X., Liu, C., Meng, D., Pang, X.-Q., He, M., Liu, G., Zhang, C., Yang, D., et al. (2022) · Molecules · doi:10.3390/molecules27144416 · Cited by 11
“ARG-1, the molecular marker of the M2 macrophages, is highly prevalent in cancer cells [34].”
BackgroundHuman placental mesenchymal stem cells regulate inflammation via the NF‑κB signaling pathway
Liu, Y., Zhang, X., Hu, Y., Kang, M., Wu, Y., Wang, Y., & Deng, C. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11591 · Cited by 12
“Macrophages, which are present in almost all tissues, play important roles in the main‐ tenance of tissue homeostasis (2).”
BackgroundGómez-Cambronero, J., Fite, K., & Miller, T. E. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.08.002 · Cited by 11
“Regarding the enzymatic activity, the product PA is highly mitogenic and has been shown to be involved in regulation of tumorigenesis, cell proliferation, cell invasion, and cell movement including metastasis (Lee et al., 2007, 2009; Hao et al., 2012).”
BackgroundBalgetir, M. K., Tektemur, N. K., Tektemur, A., Türk, G., Güngör, İ. H., Cihangiroğlu, A. Ç., Akkoç, R. F., Kuloğlu, T., & Dabak, D. Ö. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01519-6 · Cited by 10
“Classically activated M1 macrophages are proinflammatory cells that are activated by LPS, IFN and GM-CSF, and produce high levels of such cytokines as TNF-α, IL-1, IL-6, IL-12 and IL-23 [13].”
BackgroundOgunlusi, O., Sarkar, M., Carter, K., Chakrabarti, A., Boland, D. J., Nguyen, T., Sampson, J., Nguyen, C. N., Fails, D. M., Jones‐Hall, Y., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03597-5 · Cited by 10
Chabeli, M. S., Wang, X., Liang, Y., Chen, C., Yang, C., Shou, Y., Wang, S., & Chen, K. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100621 · Cited by 10
Lu, G., & Qiu, Y. (2023) · Molecular Carcinogenesis · doi:10.1002/mc.23663 · Cited by 10
New sights of immunometabolism and agent progress in colitis associated colorectal cancer
Zhang, J., Chen, C., Yan, W., & Fu, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1303913 · Cited by 11
“…fi es a metabolic transition in cancer cells from aerobic mitochondrial oxidation to glycolysis in order to supply the energy required for accelerated cell proliferation (Hao et al., 2012; Ip et al., 2017), which is a master feature of tumor cells and leads to the accumulation of lactate in TME.”
BackgroundChi, H., Lin, Y.-H., Wu, Y., Chang, C., Wu, C., Yeh, C., Hsieh, C., & Lin, K. (2024) · American Journal of Cancer Research · doi:10.62347/vctw6889 · Cited by 10
“Within the TME, M1 macrophages are characterized by low IL-10 expression, elevated levels of cytokines (IL-12, IL-1β, TNFα, IL-6), along with che - mokine interactions (CXCL9, CXCL10) that attract Th1 lymphocytes [11, 12].”
Tumor-Associated Macrophages, Inflammation and Pathogenesis of Hepatocellular Carcinoma
Lewis, M. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000132 · Cited by 11
“Both of these macrophage sub-types induce T helper immune responses, M1 macrophages induce T helper 1 cytotoxic immune response through the expression of many pro-inflammatory signals, whereas M2 macrophages trigger a T helper 2 immune response and secrete a number of anti-inflammatory signals, thus creating a procanc…”
BackgroundUpdate on the challenges and recent advances in cancer immunotherapy
Baronzio, G., Parmar, G., Ballerini, M., Mikhail, K., Valter, C., Shubina, I. Z., & Giuli, S. (2013) · ImmunoTargets and Therapy · doi:10.2147/itt.s30818 · Cited by 10
“Resident cells initially try to continue their homeostatic existence controlling tumor growth but are eventually substituted by more immature cells – myeloid-derived suppressor cells (MDSCs) – recruited by bone marrow.(13,14) Once MDSCs arrive into the tumor area, they are quickly differentiated into cells such as typ…”
Zhang, Y., Dai, J., Huang, W.-F., Chen, Q., Chen, W., He, Q., Chen, F., & Zhang, P. (2021) · Aging · doi:10.18632/aging.203784 · Cited by 10
“On the contrary, M2 macrophages inhibit inflammatory responses and create an immunosuppressive microenvironment for tumor growth, metastasis, and angiogenesis [19].”
BackgroundConstruction of an M2 macrophage-related prognostic model in hepatocellular carcinoma
Song, H., Wang, X., Zhang, C., & He, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1170775 · Cited by 10
Saleh, N. A., Rode, M. P., Cisilotto, J., Silva, A. H., Prigol, A. N., Efe, F. D. L., Winter, E., Filippin-Monteiro, F. B., & Creczynski‐Pasa, T. B. (2023) · Immunological Investigations · doi:10.1080/08820139.2023.2278774 · Cited by 10
“External stimulus can induce macrophages to a coordinated gene expression change, altering the functional capacity of the cell to a pro or anti-inflammatory profile (Hao et al., 2012; Mosser & Edwards, 2008).”
BackgroundCancer Immunoediting: Immunosurveillance, Immune Equilibrium, and Immune Escape
Bhatia, A., & Kumar, Y. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_12 · Cited by 10
Luo, Y.-H., Wu, Z. W., Tsai, H.-T., Lin, S., & Lin, P. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b01809 · Cited by 10
Tieng, F. Y. F., Lee, L., & Mutalib, N. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959705 · Cited by 11
Krpina, K., Babarović, E., Španjol, J., Đorđević, G., Maurer, T., & Jonjić, N. (2015) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0907-3 · Cited by 10
Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma
Chillà, A., Margheri, F., Biagioni, A., Rosso, T. D., Fibbi, G., Rosso, M. D., & Laurenzana, A. (2020) · Cancers · doi:10.3390/cancers12071771 · Cited by 10
“Indeed, monocytes are the source of tumor-associated Mφs (TAMs) and dendritic cells (DCs), with different properties in shaping the pro- or anti-inflammatory cancer microenvironment [81].”
BackgroundZhang, N., Zhao, F., Chen, H., Wang, J., & Li, H. (2025) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70034 · Cited by 9
Song, J., Sun, L., Li, F., Wang, D., Yang, S., Ai, Y., Jiang, N., & Song, W. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04043-8 · Cited by 9
“In terms of macrophage regulation, extreme M2 polarization may promote the occurrence and development of tumors, and maintaining a healthy M1/M2 ratio is important for tissue repair [225].”
Self-citationChen, J., Ye, Z., Liu, L., & Xuan, B. (2022) · Translational Andrology and Urology · doi:10.21037/tau-22-161 · Cited by 9
Zhang, X. (2023) · IET Systems Biology · doi:10.1049/syb2.12074 · Cited by 9
“They produce factors that promote tumour growth and invasion, hinder the function of effector T cells, and recruit regulatory T cells (Tregs) [7–9].”
BackgroundGao, X., Yang, H., Chu, Y., Zhang, W., Wang, Z., & Ji, L. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106385 · Cited by 9
Li, C., Wang, L., Li, Z., Li, Z., Zhang, K., Cao, L., Wang, Z., Shen, C., & Chen, L. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123729 · Cited by 9
Vallerand, D., Massonnet, G., Kebir, F., Gentien, D., Maciorowski, Z., de la Grange, P., Sigal‐Zafrani, B., Richardson, M., Humbert, S., Thuleau, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157670 · Cited by 9
“We determined the macrophage-like cell activation phenotype, by sorting macrophage-like cells fromMMTV-PyMT/BC-PyMT and PDXs and evaluating gene expression and protein levels for well-defined M1 and M2 markers [36, 37].”
MethodBasu, A., Dvorina, N., Baldwin, W. M., & Mazumder, B. (2020) · The FASEB Journal · doi:10.1096/fj.201903119r · Cited by 9
Yang, D., Zhang, X., Li, Z., Xu, F., Tang, C., & Chen, H. (2021) · PeerJ · doi:10.7717/peerj.11512 · Cited by 9
Zeng, R., Wu, H., Qiu, X., Zhuo, Z., Sha, W., & Chen, H. H. (2021) · QJM · doi:10.1093/qjmed/hcab334 · Cited by 10
Chen, J., Wang, G., Zhang, D., Luo, X., Zhang, D., & Zhang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075431 · Cited by 9
“Hypoxia-induced cancer factors including IL-10 and TGF-beta can cause tumor-associated macrophages to develop into M2 macrophages, which have immunosuppressive properties (51).”
BackgroundВалерьевич, К. С., Lyamina, S., Витальевна, Ч. С., Kochetova, L., Malyshev, Y., Manukhina, E. B., & Malyshev, I. Y. (2015) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.895555 · Cited by 11
Understanding dendritic cell immunotherapy in ovarian cancer
Drakes, M. L., & Stiff, P. J. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2016.1178576 · Cited by 9
Weber, M., Söder, S., Sander, J., Ries, J., Geppert, C. I., Kesting, M. R., & Wehrhan, F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00745 · Cited by 9
Kantola, T., Klintrup, K., Väyrynen, J. P., Vornanen, J., Bloigu, R., Karhu, T., Herzig, K., Näpänkangas, J. P., Mäkelä, J. T., Karttunen, T. J., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.162 · Cited by 9
“Tumour-associated macrophages activated towards M2 phenotype are generally considered to promote tumour growth by enhancing angiogenesis, growth, metastasis and immunosuppression (Baay et al, 2011, Hao et al, 2012).”
BackgroundNatural killer cell-based therapies in neuroblastoma
Ghasempour, A., Mohseni, R., Sharif, P. M., & Hamidieh, A. A. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104898 · Cited by 9
Obeagu, E. I. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003295 · Cited by 8
“Future studies should focus on integrating cytokine biology into the broader understanding of the TME, aiming to develop personalized and context-specific therapeutic strategies [ 24 ] .”
Pawłowska, M., Jarek, D. J., Milanowski, J., & Szewczyk‐Golec, K. (2025) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2025.071891 · Cited by 8
“They secrete anti-inflammatory cytokines such as IL-10 and TGF-β, support angiogenesis, and inhibit effective antitumor responses [111].”
Mechanisms Underlying Tumor-Associated Macrophages (TAMs)-Facilitated Metastasis
Aleebrahim‐Dehkordi, E., Deravi, N., Fallahi, M. S., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_66-1 · Cited by 9
Metadata
- Authors
- Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M.
- Affiliations
- Army Medical University (CN)
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
- Biomedical Analysis Center, Third Military Medical University, Chongqing 40038, China
- Corresponding author
- Zhang, Zhi-Ren
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3385963
- OpenAlex
- W2106027870
- Cited by
- 1,003
- References
- 121
- Citations by year
- 2026: 28 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 81 · 2021: 109 · 2020: 86 · 2019: 60 · 2018: 65 · 2017: 70 · 2016: 73 · 2015: 85 · 2014: 69 · 2013: 68 · 2012: 2
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor microenvironment, macrophage polarization, M1 macrophages, M2 macrophages, immunosuppression, tumor angiogenesis, metastasis, cancer stem cells, drug resistance, macrophage-targeted therapy
- MeSH terms
- Animals, Humans, Macrophages, Neoplasms, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.